Introducing GLP-1 Drugs GLP-1 receptor agonists were developed to treat type 2 diabetes and obesity by mimicking a hormone that regulates blood sugar and appetite
It has no estrogenic, glucocorticoid, and anti-glucocorticoid activity
Weve seen strong demand for products that support blood sugar management, which are particularly popular among customers curious about GLP-1 or those transitioning off these medications, says Mark Butera, vice president of merchandising
After that, each refill including physician review, a personalized plan, a detailed metabolic report, and shipping runs $299
Administration: Inject subcutaneously once weekly on the same day in the stomach, thigh, or upper arm
The severity and duration of nausea vary considerably between individuals and between different GLP-1 preparations